SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-06-017359
Filing Date
2006-03-16
Accepted
2006-03-16 16:22:09
Documents
10
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT PURSUANT TO SECTION 13 AND 15(D) a06-6794_110k.htm 10-K 1264356
2 SUBSIDIARIES OF THE REGISTRANT a06-6794_1ex21d1.htm EX-21.1 5281
3 CONSENTS OF EXPERTS AND COUNSEL a06-6794_1ex23d1.htm EX-23.1 4226
4 302 CERTIFICATION a06-6794_1ex31d1.htm EX-31.1 9144
5 302 CERTIFICATION a06-6794_1ex31d2.htm EX-31.2 9158
6 906 CERTIFICATION a06-6794_1ex32d1.htm EX-32.1 6148
7 GRAPHIC g67941dai001.jpg GRAPHIC 35785
8 GRAPHIC g67941dai002.jpg GRAPHIC 23839
9 GRAPHIC g67941dai003.jpg GRAPHIC 11593
10 GRAPHIC g67941dci001.jpg GRAPHIC 39498
  Complete submission text file 0001104659-06-017359.txt   1452935
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Filer) CIK: 0001037649 (see all company filings)

IRS No.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32715 | Film No.: 06692251
SIC: 2835 In Vitro & In Vivo Diagnostic Substances